Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Keytruda Bladder Cancer Advisory Cmte. To Discuss Clinical Meaningfulness Of Complete Response Rate
Dec 16 2019
•
By
Derrick Gingery
The only other treatment approved in the proposed high-risk bladder cancer indication is not in treatment guidelines due to lack of efficacy. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers